FGF23 is associated with disease severity and prognosis in chronic heart failure-Reference-Cited by-同舟云学术

FGF23 is associated with disease severity and prognosis in chronic heart failure

Published:2014-11-03 Issue:12 Volume:44 Page:1150-1158
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Poelzl Gerhard¹,Trenkler Christian¹,Kliebhan Johannes¹,Wuertinger Philipp²,Seger Christoph²,Kaser Susanne³,Mayer Gert⁴,Pirklbauer Markus⁴,Ulmer Hanno⁵,Griesmacher Andrea²

Affiliation:

1. Clinical Division of Cardiology; Innsbruck Medical University; Innsbruck Austria

2. Central Institute for Medical and Chemical Laboratory Diagnosis; Innsbruck University Hospital; Innsbruck Austria

3. Clinical Division of Internal Medicine and Endocrinology; Innsbruck Austria

4. Clinical Division of Nephrology and Hypertensiology; Innsbruck Austria

5. Department of Medical Statistics; Informatics and Health Economics; Innsbruck Medical University; Innsbruck Austria

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/eci.12349/fullpdf

Reference40 articles.

1. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure;Hillege;Circulation,2006

2. Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance;Poelzl;Eur J Clin Invest,2012

3. Concomitant renal and hepatic dysfunctions in chronic heart failure: clinical implications and prognostic significance;Poelzl;Eur J Int Med,2013

4. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure;Shane;Am J Med,1997

5. Update on fibroblast growth factor 23 in chronic kidney disease;Wolf;Kidney Int,2012

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic kidney disease associated cardiomyopathy: recent advances and future perspectives;Current Opinion in Nephrology & Hypertension;2024-01-05

2. Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction;BMC Cardiovascular Disorders;2023-09-01

3. FGF23 and klotho at the intersection of kidney and cardiovascular disease;Nature Reviews Cardiology;2023-07-13

4. Direct and indirect effects of fibroblast growth factor 23 on the heart;Frontiers in Endocrinology;2023-02-24

5. Fibroblast growth factor 23 in children with or without heart failure: a prospective study;BMJ Paediatrics Open;2023-02